Theravance Biopharma Overview

Life ScienceCompany

Where is Theravance Biopharma headquartered?

Theravance Biopharma is headquartered in South San Francisco, California.

What is Theravance Biopharma’s revenue?

Theravance Biopharma disclosed revenue of 64M USD for 2024 and 57M USD for 2023.

How many employees does Theravance Biopharma have?

Theravance Biopharma has 97 employees.

What sector is Theravance Biopharma in?

Theravance Biopharma is a life science company.

When was Theravance Biopharma founded?

Theravance Biopharma was founded in 2013.

Theravance Biopharma

Theravance Biopharma, Inc.

901 Gateway Boulevard,
South San Francisco, California 94080
United States,
(650) 808-6000
www.theravance.com

Theravance Biopharma is a biopharmaceutical company with one approved product, VIBATIV® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance Biopharma was founded in 2013 and is based in George Town, Caymen Islands.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.2/yr) # 1 - - - - 1 2
vol $20M $225M $245M
  2

Top M&A Advisors

Financial Deals
Lazard
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.